Mike’s Patient Story

Discover Mike Stansbury’s journey of resilience and hope while battling uveal melanoma, a type of cancer that occurs in the eye and can spread to other parts of the body. Thanks to the power of clinical trials, Mike now shows no evidence of disease and is back to doing what he loves most: competing in professional golf tournaments.

At SCRI, we know that the majority of cancer patients, like Mike, seek care in their own communities. The delivery of innovative clinical trials within the community setting is imperative.

SCRI provides clinical trials in the community faster through Accelero, our scaled seamless operations model to accelerate drug development. Accelero transforms clinical trial delivery and redefines clinical research in the community. Coordinated through our CRO, SCRI Development Innovations, Accelero enhances connectivity to SCRI research sites, which in turn maximizes site contributions, optimizes site activation timelines, and synchronizes end-to-end clinical research management. Accelero offers a comprehensive and integrated approach that enables optimal site performance and facilitates the seamless execution of clinical trials.

Learn more about Accelero.